Indian drug wholesalers withhold stocks to protest price cuts

06/11/2013 | Times of India, The

India's FDA has threatened to take action against drug wholesalers who have halted purchases of fresh drugs and medical supplies to protest price reductions that they say are cutting their profit margins by almost half or more. The new National Pharmaceutical Pricing Policy expands direct regulation from 74 to 348 essential drugs, cuts prices of some drugs by 20% to 25% and by as much as 80% for several designated lifesaving medications.

View Full Article in:

Times of India, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC